2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$15.51-$0.005 (-0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.7BMarket Cap
- 27.65%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$15.51-$0.005 (-0.03%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.51 | ||
Change | +$0.16 (+1.04%) | ||
Open | $15.50 | ||
High | $16.00 | ||
Low | $15.35 | ||
Previous Close | $15.35 | ||
Volume | 1,127,182 | ||
30-Day Average Volume | 1,213,440 | ||
1-Week Change | -13.55% | ||
1-Month Change | -12.17% | ||
1-Year Change | 27.65% | ||
3-Year Change | -24.30% | ||
5-Year Change | -88.23% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $795.2M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $183.6M | ||
Net Income | -$15.7M | ||
Free Cash Flow | $1.2M | ||
EBIT | -$10.6M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $417.8M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -293 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 5 | ||
P/E | -119 | ||
PEG | -2 | ||
Price/Free Cash Flow | 1,422 | ||
Price/Operating Cash Flow | 213 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue